Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
NCT07713940 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2026-07-20
Summary
To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus
Conditions
- Systemic Lupus Erthematosus (SLE)
Interventions
- DIETARY_SUPPLEMENT
-
anti-inflammatory diet
anti-inflammatory diet for 6 weeks
Sponsors & Collaborators
-
University of California, San Diego
lead OTHER
Principal Investigators
-
Monica Guma, MD, PhD · UC San Diego
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-01
- Primary Completion
- 2028-07-01
- Completion
- 2029-07-01
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT00987831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
NCT06032923 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT07311200 ·Status: RECRUITING ·Phase: PHASE2
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus
NCT05379725 ·Status: TERMINATED ·Phase: NA
-
Effect of Curcumin on Systemic Lupus Erythematosus
NCT03953261 ·Status: TERMINATED ·Phase: PHASE2
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
Efficacy of Vitamin C Supplementation on Serum IL-6 Levels and Disease Activity in Systemic Lupus Erythematosus Patients
NCT07071220 ·Status: COMPLETED ·Phase: NA
-
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
NCT07123220 ·Status: COMPLETED
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285 ·Status: RECRUITING
-
T Regulatory Cells IN LUPUS NEPHRITIS
NCT06428539 ·Status: NOT_YET_RECRUITING
-
Epigenetics in Lupus Nephritis
NCT04648059 ·Status: UNKNOWN
-
Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization
NCT03142412 ·Status: UNKNOWN
-
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
NCT06625671 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus
NCT00556192 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus
NCT03161483 ·Status: COMPLETED ·Phase: PHASE2
-
Interleukin23 in Systemic Lupus
NCT06713187 ·Status: RECRUITING ·Phase: NA
-
Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis
NCT00371319 ·Status: COMPLETED ·Phase: PHASE4
-
Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE
NCT01702038 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Long-Term Outcomes in SLE at Peking University People's Hospital
NCT07005479 ·Status: RECRUITING
-
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
NCT02391259 ·Status: COMPLETED ·Phase: PHASE1